TY - JOUR
T1 - 46,XY disorders of sex development - The undermasculinised male with disorders of androgen action
AU - Werner, Ralf
AU - Grötsch, Helga
AU - Hiort, Olaf
N1 - Funding Information:
We apologize to authors whose work could not be cited due to space constraints. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 201444.
Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2010/4
Y1 - 2010/4
N2 - Insensitivity to the action of androgens is a common cause of undermasculinisation in 46,XY individuals. These disorders are a result of the failure of major androgens to act via the intracellular androgen receptor and, thus, the genomic effects of androgen signalling are disrupted. The phenotype of affected individuals can vary considerably, depending on the dysfunction of the receptor. In childhood, the diagnosis is often complicated due to the lack of sensitive biochemical determinants, whilst during adolescence and in adults, the diagnosis can be readily made because of the striking clinical feminisation and a conclusive laboratory analysis. A variety of mutations in the androgen receptor have been analysed, providing insight into the complex pathways of intracellular processing and signal transduction via the androgen receptor. Endocrine therapy in androgen-insensitivity syndrome is controversial, because till date the special hormonal profiles in androgen insensitivity have not been acknowledged in replacement strategies.
AB - Insensitivity to the action of androgens is a common cause of undermasculinisation in 46,XY individuals. These disorders are a result of the failure of major androgens to act via the intracellular androgen receptor and, thus, the genomic effects of androgen signalling are disrupted. The phenotype of affected individuals can vary considerably, depending on the dysfunction of the receptor. In childhood, the diagnosis is often complicated due to the lack of sensitive biochemical determinants, whilst during adolescence and in adults, the diagnosis can be readily made because of the striking clinical feminisation and a conclusive laboratory analysis. A variety of mutations in the androgen receptor have been analysed, providing insight into the complex pathways of intracellular processing and signal transduction via the androgen receptor. Endocrine therapy in androgen-insensitivity syndrome is controversial, because till date the special hormonal profiles in androgen insensitivity have not been acknowledged in replacement strategies.
UR - http://www.scopus.com/inward/record.url?scp=77956622556&partnerID=8YFLogxK
U2 - 10.1016/j.beem.2009.11.002
DO - 10.1016/j.beem.2009.11.002
M3 - Scientific review articles
C2 - 20541151
AN - SCOPUS:77956622556
SN - 1521-690X
VL - 24
SP - 263
EP - 277
JO - Best Practice and Research: Clinical Endocrinology and Metabolism
JF - Best Practice and Research: Clinical Endocrinology and Metabolism
IS - 2
ER -